1 / 15

Prospective Studies Collaboration Lancet 2009; 373: 1083-96

Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Prospective Studies Collaboration Lancet 2009; 373: 1083-96. Blood pressure, cholesterol and BMI. Blood pressure. Cholesterol. 160. 5. M. Non-HDL-C. Systolic. M.

mckenzie-wall
Download Presentation

Prospective Studies Collaboration Lancet 2009; 373: 1083-96

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies Prospective Studies Collaboration Lancet 2009; 373: 1083-96

  2. Blood pressure, cholesterol and BMI Blood pressure Cholesterol 160 5 M Non-HDL-C Systolic M Ratio of means (non-HDL-C/HDL-C) 140 4 F F M 120 3 F mmol/L (or ratio) mm Hg 100 2 F M Diastolic HDL-C 80 F 1 M 0 15 25 35 50 15 25 35 50 Baseline BMI (kg/m2) Adjusted for age, smoking and study Fig 1a & b, Lancet 2009; 373: 1083-96

  3. Ratio non-HDL:HDL cholesterol and BMI 5 M Mean of ratios 4 Ratio of means 3 F Ratio (Mean of ratios ~10% higher than ratio of means) 2 1 0 15 25 35 50 Baseline BMI (kg/m2) Adjusted for age, smoking and study Fig 1b variant, Lancet 2009; 373: 1083-96

  4. Drinking, smoking, diabetes and BMI Female Male 100 100 80 80 Drinking 60 60 Prevalence% 40 40 Drinking Smoking 20 20 Smoking Diabetes Diabetes 0 0 15 25 35 50 15 25 35 50 Baseline BMI (kg/m2) Adjusted for age, smoking and study Fig 1c & d, Lancet 2009; 373: 1083-96

  5. All-cause mortality and BMI 64 Male 32 Annual deaths per 1000 Female 16 & 95% CI (floated so matches PSC rate at ages 35-79) 8 4 15 20 25 30 35 40 50 Baseline BMI (kg/m2) Adjusted for age, smoking and study; 1st 5 years of follow-up excluded Fig 2, Lancet 2009; 373: 1083-96

  6. IHD and stroke mortality and BMI IHD 8 4 Annual deaths per 1000 Stroke 2 & 95% CI (floated so matches PSC rate at ages 35-79) 1 0·5 15 20 25 30 35 40 50 Baseline BMI (kg/m2) Adjusted for age, sex, smoking and study; 1st 5 years of follow-up excluded Fig 3, Lancet 2009; 373: 1083-96

  7. Main mortality categories and BMI Male Female 14 14 Vascular 12 12 Annual deaths per 1000 10 10 8 8 6 6 Vascular & 95% CI (floated so matches EU rate at ages 35-79) Cancer (other specified) 4 4 Cancer (other specified) Cancer (lung, mouth, pharynx, larynx, oes.) 2 2 Cancer (lung, mouth, pharynx, larynx, oes.) Resp. Respiratory 0 0 15 20 25 30 35 50 15 20 25 30 35 50 Baseline BMI (kg/m2) Adjusted for age, smoking and study; 1st 5 years of follow-up excluded Fig 5, Lancet 2009; 373: 1083-96

  8. All-cause mortality and BMI, by smoking 30 Current cigarette smoker 25 Annual deaths per 1000 20 Never smoked regularly 15 & 95% CI (floated so matches EU rate at ages 35-79) 10 (N.B. The vertical separation of the curves underestimates effects of lifelong cigarette smoking) 5 0 15 20 25 30 35 50 Baseline BMI (kg/m2) Adjusted for age, sex and study; 1st 5 years of follow-up excluded Fig 6, Lancet 2009; 373: 1083-96

  9. Lifespan and BMI in western Europe, year 2000 Male Female 100 100 88% 80 80 77% 84% 69% % alive 60 60 Yearly dots 40 40 BMI range, kg/m2 22.5-25 (mean 24) 20 20 25-30 (mean 27) 30-35 (mean 32) 0 0 40 50 60 70 80 90 100 40 50 60 70 80 90 100 Age (years) Causal PSC relative risks applied to EU mortality rates Fig 7 variant, Lancet 2009; 373: 1083-96

  10. Lifespan and BMI in western Europe, year 2000 Male Female 100 100 88% 77% 80 80 72% 60 60 % alive Yearly dots 49% BMI range, kg/m2 40 40 22.5-25 (mean 24) 25-30 30-35 (mean 32) 20 20 35-40 40-50 (mean 43) 0 0 40 50 60 70 80 90 100 40 50 60 70 80 90 100 Age (years) Causal PSC relative risks applied to EU mortality rates Fig 7, Lancet 2009; 373: 1083-96

  11. Comparison with smoking in the British Doctors’ Study From figure 3 in Doll, Peto et al., BMJ 2004: 328: 1519-33

  12. All-cause mortality and BMI by smoking Male (35-69 years) Female (35-69 years) 20 20 Current cigarette smoker 15 15 Annual deaths per 1000 Never smoked regularly Current cigarette smoker 10 10 & 95% CI (floated so matches EU rate at ages 35-69) Never smoked regularly 5 5 0 0 15 20 25 30 35 50 15 20 25 30 35 50 Baseline BMI (kg/m2) Adjusted for age and study; 1st 5 years of follow-up excluded Webfig 7a & b, Lancet 2009; 373: 1083-96

  13. All-cause mortality and BMI by smoking Male (70-79 years) Female (70-79 years) 100 100 Current cigarette smoker 75 75 Annual deaths per 1000 Never smoked regularly Current cigarette smoker 50 50 & 95% CI (floated so matches EU rate at ages 70-79) Never smoked regularly 25 25 0 0 15 20 25 30 35 50 15 20 25 30 35 50 Baseline BMI (kg/m2) Adjusted for age and study; 1st 5 years of follow-up excluded Webfig 7c & d, Lancet 2009; 373: 1083-96

  14. Vascular mortality and BMI by smoking Male (35-69 years) Female (35-69 years) 6 6 Current cigarette smoker Annual deaths per 1000 4 4 Never smoked regularly Current cigarette smoker & 95% CI (floated so matches EU rate at ages 35-69) 2 2 Never smoked regularly 0 0 15 20 25 30 35 50 15 20 25 30 35 50 Baseline BMI (kg/m2) Adjusted for age and study; 1st 5 years of follow-up excluded Webfig 8a & b, Lancet 2009; 373: 1083-96

  15. Vascular mortality and BMI by smoking Male (70-79 years) Female (70-79 years) 30 30 Current cigarette smoker Annual deaths per 1000 Never smoked regularly 20 20 Current cigarette smoker & 95% CI (floated so matches EU rate at ages 35-79) Never smoked regularly 10 10 0 0 15 20 25 30 35 50 15 20 25 30 35 50 Baseline BMI (kg/m2) Adjusted for age and study; 1st 5 years of follow-up excluded Webfig 8c & d, Lancet 2009; 373: 1083-96

More Related